Search results for "Ceph"

showing 10 items of 2036 documents

Clinical evaluation criteria for the assessment of impaired pain sensitivity by thulium-laser evoked potentials

2000

Abstract Objectives : Cortical potentials evoked by carbon dioxide laser pulses have been applied in clinical practice to study nociceptive pathways for several years. In this study, we evaluate the properties of an infrared laser (thulium-YAG) with a penetration depth in the skin that matches the intracutaneous depth of nociceptors. Methods : Temperature measurements and modelling showed that the thulium laser generates painful intracutaneous temperatures with less surface heating than the carbon dioxide laser and with no side effects (up to 600 mJ pulse energy). To develop clinical evaluation criteria, laser-evoked potentials (LEPs) were recorded from 3 midline positions (Fz, Cz, Pz) vers…

AdultMalePain Thresholdmedicine.medical_specialtyLaser-Evoked PotentialsInfrared Raysmedicine.medical_treatmentAudiologyEvoked Potentials SomatosensoryPhysiology (medical)medicineNoxious stimulusHumansNeurons AfferentParesthesiaHabituationHabituation Psychophysiologicbusiness.industryElectrodiagnosisLasersNociceptorsReproducibility of ResultsDissociated sensory lossElectroencephalographyMiddle AgedCarbon dioxide lasermedicine.diseaseSensory SystemsElectrophysiologyNociceptionNeurologySomatosensory evoked potentialThuliumAnesthesiaFemaleNeurology (clinical)businessClinical Neurophysiology
researchProduct

Effects of transcranial direct current stimulation of the primary sensory cortex on somatosensory perception.

2011

Background: Transcranial direct current stimulation (tDCS) is able to modify cortical excitability and activity in humans. Objective: The aim of the present study was to analyze the effects of tDCS of the primary sensory cortex (SI) on thermal and mechanical perception, assessed by quantitative sensory testing (QST). Methods: The comprehensive QST protocol encompassing thermal and mechanical detection and pain thresholds as devised by the German Research Network on Neuropathic Pain (DFNS) was applied to skin areas innervated by the radial and median nerve of 12 healthy subjects, who were examined before and after each tDCS stimulation type. Anodal, cathodal, and sham tDCS was applied at a 1…

AdultMalePain Thresholdmedicine.medical_specialtymedicine.medical_treatmentBiophysicsquantitative sensory testingStimulationAudiologySomatosensory system050105 experimental psychologyFunctional Lateralitylcsh:RC321-57103 medical and health sciencesYoung Adult0302 clinical medicineEvoked Potentials SomatosensoryPhysical StimulationSensationThreshold of painmedicineReaction TimeHumans0501 psychology and cognitive sciencesThermosensinglcsh:Neurosciences. Biological psychiatry. NeuropsychiatryAnalysis of VarianceTranscranial direct-current stimulationGeneral Neuroscience05 social sciencesTemperatureElectroencephalographySomatosensory CortexQSTTranscranial Magnetic StimulationTranscranial magnetic stimulationHyperalgesiaNeuropathic painFemaleNeurology (clinical)transcranial direct current stimulationPrimary motor cortexPsychologyNeuroscience030217 neurology & neurosurgeryBrain stimulation
researchProduct

Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET

2009

Abstract Transcranial ultrasound (TCS) has been shown to reveal hyperechogenicity of the substantia nigra (SN) in Parkinsonian patients and in about 10% of healthy controls. It is hypothesized that SN hyperechogenicity in healthy subjects is a vulnerability marker for idiopathic Parkinson's disease (IPD). Although there is strong evidence that the echomarker results from increased local iron content, the exact pathophysiological mechanisms remain incompletely understood. Thus, prognostic impact can only be estimated. We examined 14 subjects with SN hyperechogenicity (SN+) (7 IPD patients and 7 controls) and 7 healthy controls without the echomarker (SN−) by a magnetic resonance imaging meth…

AdultMalePathologymedicine.medical_specialtyCognitive NeuroscienceSubstantia nigraReference ValuesmedicineHumansNeuronsmedicine.diagnostic_testbusiness.industryTissue inhomogeneityHealthy subjectsParkinson DiseaseMagnetic resonance imagingMiddle AgedEchoencephalographyMagnetic Resonance ImagingPathophysiologyDihydroxyphenylalanineTranscranial DopplerSubstantia NigraNeurologyPositron-Emission TomographyT2 relaxationIron contentFemaleRadiopharmaceuticalsbusinessNeuroImage
researchProduct

Electrophysiological and MRI findings in 2 patients with Listeria rhombencephalitis.

1997

AdultMalePathologymedicine.medical_specialtyElectrodiagnosisMeningitis Listeriamedicine.disease_causeCentral nervous system diseaseListeria monocytogenesmedicineEvoked Potentials Auditory Brain StemHumansListeriosismedicine.diagnostic_testbiologyBlinkingReflex Abnormalbusiness.industrymedicine.diseasebiology.organism_classificationPrognosisMagnetic Resonance ImagingElectrophysiologyNeurologyListeriaEncephalitisFemaleNeurology (clinical)businessMri findingsEncephalitisBrain StemEuropean neurology
researchProduct

Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: A case report

2002

Reversible posterior leukoencephalopathy syndrome (RPLS) is an uncommon entity related to multiple and different pathologies, the most common being hypertensive crisis. It is believed to be secondary to the breakdown on the blood-brain barrier. At the beginning, it is undistinguishable from other leukoencephalopathies. However, the disappearance of brain lesions after removal of the potential cause, establish the differential diagnosis with other leukoencephalopathies. We present the case of an HIV-infected patient with a RPLS related to a hypertensive crisis short after the initiation of indinavir-containing highly active antiretroviral therapy. Once blood pressure was controlled and indin…

AdultMalePathologymedicine.medical_specialtyHypertensive encephalopathymedicine.medical_treatmentHIV InfectionsIndinavirIndinavirAntiretroviral Therapy Highly ActiveHypertensive EncephalopathyInternal MedicinemedicineHumansChemotherapymedicine.diagnostic_testbusiness.industryProgressive multifocal leukoencephalopathyvirus diseasesMagnetic resonance imagingHIV Protease Inhibitorsmedicine.diseaseMagnetic Resonance ImagingHyperintensityNelfinavirDifferential diagnosisbusinessmedicine.drugAmerican Journal of Hypertension
researchProduct

The spontaneous burst activity of peripheral blood monocytes in patients with acute polyradiculoneuritis, lymphocytic meningoencephalitis, and multip…

1986

Abstract The course of the spontaneous burst activity (BA) of peripheral blood monocytes was examined in patients with acute polyradiculoneuritis (PN), lymphocytic meningoencephalitis (LE), and multiple sclerosis (MS) and the BA was compared with the clinical course. In 4 patients with postinfectious acute PN the BA was significantly increased up to values around 60000 counts/10 s. The BA and the clinical course were closely correlated in these patients (mean of r = 0.83). In 4 patients with lymphocytic LE the BA initially was moderately increased to values between 4000 and 5000 counts/10 s and showed again a very close correlation with the clinical course (mean of r = 0.99) In 13 MS patien…

AdultMalePathologymedicine.medical_specialtyMultiple SclerosisAdolescentPolyradiculoneuropathySigns and symptomsMonocytesMeningoencephalitisHumansMedicineIn patientLymphocytesbusiness.industryMultiple sclerosisClinical courseMiddle Agedmedicine.diseasePeripheral bloodLymphocytic meningoencephalitisNeurologyAcute DiseaseLuminescent MeasurementsFemaleNeurology (clinical)businessJournal of the Neurological Sciences
researchProduct

Unusual MRI findings in an immunocompetent patient with EBV encephalitis: a case report.

2011

Abstract Blackground It is well-known that Epstein-Barr virus (EBV) can affect the central nervous system (CNS). Case presentation Herein the authors report unusual timely Magnetic Resonance Imaging (MRI) brain scan findings in an immunocompetent patient with EBV encephalitis. Diffusion weighted MRI sequence performed during the acute phase of the disease was normal, whereas the Fast Relaxation Fast Spin Echo T2 image showed diffuse signal intensity changes in white matter. The enhancement pattern suggested an inflammatory response restricted to the brain microcirculation. Acyclovir and corticosteroid therapy was administered. After three weeks, all signal intensities returned to normal and…

AdultMalePathologymedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaEpstein-Barr virus encephalitis MRI Diffusion-weighted imaginglcsh:Medical technologyMononucleosisSettore MED/17 - Malattie InfettiveencephalitisCentral nervous systemCase Reportmedicine.disease_causeWhite matterImmunocompromised HostNeuroimagingmedicineHumansEpstein-Barr virusRadiology Nuclear Medicine and imagingInfectious Mononucleosismedicine.diagnostic_testbusiness.industrySettore MED/37 - NeuroradiologiaMagnetic resonance imagingmedicine.diseaseEpstein–Barr virusMagnetic Resonance Imagingmedicine.anatomical_structurelcsh:R855-855.5Radiology Nuclear Medicine and imagingDiffusion-weighted imagingbusinessEncephalitisDiffusion MRIMRIBMC medical imaging
researchProduct

Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study

2009

Summary Purpose To report on the first multicenter Italian experience with zonisamide as an add-on drug for refractory generalised or partial epilepsy in children, adolescents and young adults. Methods The patients were enrolled in a prospective, add-on, open-label treatment study from eight Italian centres for children and adolescent epilepsy care. Eighty-two young patients (45 males, 37 females), aged between 3 and 34 years (mean 13.1 years), all affected by partial (47) or generalised (35) refractory epilepsy, were enrolled in the study. ZNS was added to the baseline therapy at a starting dose of 1 mg/kg/day twice daily. This dose was increased by 2 mg/kg every 1–2 weeks over a period of…

AdultMalePediatricsmedicine.medical_specialtyAdolescentmedicine.medical_treatmentAntiepileptic drugsZonisamideIrritabilityStatistics NonparametricEpilepsyYoung AdultRefractorymedicineHumansNonparametricYoung adultAdverse effectPreschoolChildNeurologic ExaminationEpilepsybusiness.industryStatisticsElectroencephalographyDrug ToleranceIsoxazolesmedicine.diseaseMagnetic Resonance ImagingSettore MED/39 - Neuropsichiatria InfantileEpilepsy; Zonisamide; Pediatric epilepsy; Antiepileptic drugsAnticonvulsantTolerabilityNeurologyItalyZonisamideChild PreschoolAnticonvulsantsFemaleNeurology (clinical)medicine.symptombusinessPediatric epilepsyAntiepileptic drugs; Epilepsy; Pediatric epilepsy; Zonisamide; Adolescent; Adult; Anticonvulsants; Child; Child Preschool; Drug Tolerance; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Isoxazoles; Italy; Magnetic Resonance Imaging; Male; Neurologic Examination; Statistics Nonparametric; Young Adult; Neurology; Neurology (clinical)medicine.drugFollow-Up Studies
researchProduct

Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome

2011

Background:  To report on the first multicenter Italian experience with rufinamide as adjunctive drug in children, adolescents and young adults with refractory childhood-onset epileptic encephalopathies other than Lennox-Gastaut syndrome. Methods:  Thirty-eight patients (19 males, 19 females), aged between 4 and 34 (mean 13.7 ± 8.3, median 12.5), all affected by different types of childhood-onset refractory epileptic encephalopathies other than Lennox-Gastaut syndrome, were treated with rufinamide as adjunctive drug for a mean period of 11.4 months (range 3-26 months). Results:  Fifteen of 38 patients (39.5%) had a ≥50% seizure reduction in co…

AdultMalePediatricsmedicine.medical_specialtyAdolescentrufinamideRufinamideIrritabilityrefractory seizures; rufinamide; epileptic encephalopathies-childhoodYoung AdultRefractoryepileptic encephalopathies-childhoodrefractory seizuresrufinamideMedicineHumansYoung adultAdverse effectChildPreschoolepileptic encephalopathies-childhoodBrain DiseasesEpilepsybusiness.industryEpileptic encephalopathies-childhood; Refractory seizures; RufinamideTriazolesmedicine.diseaseSettore MED/39 - Neuropsichiatria Infantilerefractory seizuresMigraineepileptic encephalopathies-childhood refractory seizures rufinamideNeurologyAnesthesiaChild PreschoolVomitingAnticonvulsantsFemaleNeurology (clinical)medicine.symptombusinessEpileptic encephalopathies-childhood; Refractory seizures; Rufinamide; Adolescent; Adult; Anticonvulsants; Brain Diseases; Child; Child Preschool; Epilepsy; Female; Humans; Male; Triazoles; Young Adult; Neurology (clinical); NeurologyLennox–Gastaut syndromemedicine.drug
researchProduct

Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature

2003

Pancreatic encephalopathy is a rare complication of acute pancreatitis. Clinical features include focal neurological signs and acute onset of dementia. This picture can fluctuate over time: cyclic progression with remission and relapses has been described. We present the case of a 43-year-old man who, after an acute episode of pancreatitis, experienced five relapses, with alternating focal signs. The patient has improved, but cognitive impairment persists after a 7-year follow-up.

AdultMalePediatricsmedicine.medical_specialtyNeurologyRemission SpontaneousEncephalopathyDermatologyNeuropsychological TestsDiagnosis DifferentialRecurrencemedicineHumansDementiaNeuroradiologyBrain Diseasesbusiness.industryElectrodiagnosisGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingSurgeryParesisPsychiatry and Mental healthPancreatitisAcute DiseaseAmylasesChronic DiseaseDisease ProgressionAcute pancreatitisPancreatitisAtaxiaNeurology (clinical)NeurosurgeryCognition DisordersComplicationbusinessFollow-Up StudiesNeurological Sciences
researchProduct